Kuros Biosciences AG KUROS BIOSCIENCES ORD SHS
Kuros Biosciences AG KUROS BIOSCI.../ CH0325814116 /
0RHR
|
10/11/2024 6:34:58 PM
|
Chg.
+2.01
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
20.05CHF
|
+11.15%
|
5,959
Turnover: 118,147.04 |
-Bid Size: - |
-Ask Size: - |
724.65 mill.CHF |
- |
- |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
-0.38 CHF |
-11.63% |
| EPS Diluted: |
- CHF |
65.22% |
| Revenues per Share: |
0.92 CHF |
86.57% |
| Book Value per Share: |
1.55 CHF |
-17.64% |
| Cash Flow per Share: |
-0.24 CHF |
20.33% |
| Dividend per Share: |
- CHF |
- |
| Total |
in mill. |
|
| Revenues: |
33.56 CHF |
86.57% |
| Net Income: |
-13.73 CHF |
-5.98% |
| Operating Cash Flow: |
-8.84 CHF |
- |
| Cash and Cash Equivalents: |
14.21 CHF |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
- |
- |
| P/S Ratio: |
21.59 |
3.80 |
| P/BV ratio: |
12.78 |
2.25 |
| P/CF Ratio: |
-81.94 |
-14.43 |
| PEG: |
4.49 |
- |
| Earnings Yield: |
-1.92% |
-10.89% |
| Dividend Yield: |
- |
- |
| Market Capitalization |
|
| Market Capitalization: |
724.65 mill. CHF |
127.6 mill. CHF |
| Free Float Market Cap.: |
- CHF |
- CHF |
| Market Cap. / Employee: |
9.06 mill. CHF |
1.59 mill. CHF |
| Shares Outstanding: |
36.56 mill. |
|
Profitability
| Gross Profit Margin: |
71.31% |
| EBIT Margin: |
-39.30% |
| Net Profit Margin: |
-40.90% |
| Return on Equity: |
-24.20% |
| Return on Assets: |
-19.21% |
Financial Strength
| Liquidity I / Cash Ratio: |
107.74% |
| Liquidity II / Quick Ratio: |
156.36% |
| Liquidity III / Current Ratio: |
206.22% |
| Debt / Equity Ratio: |
26.01% |
| Dynam. Debt / Equity Ratio: |
-166.80% |
Efficiency
| Employees: |
80 |
| Personal Expenses / Employee: |
- CHF |
| Revenues / Employee: |
419,550.00 CHF |
| Net Income / Employee: |
-171,587.50 CHF |
| Total Assets / Employee: |
893,300.00 CHF |
| * Fiscal Year End: |
12/31/2023 |
| Accounting Standard: |
IFRS |
